Aim: The aim of the study is to study the utility of various inflammatory markers in predicting
outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia …

Objectives: In coronavirus disease-19 (COVID-19) pneumonia, the role of various
inflammatory markers including interleukin-6 (IL-6) was evolved in managing cases in …

Introduction: COVID-19 is a highly infectious disease and varies in the severity of
presentation as well as survival outcome due to varied inflammatory responses. Hence, the …

Background In pandemic situations, it is essential that the limited resources are used
judiciously to achieve most benefits. Prediction of the disease severity at the earliest will …

Background: Inflammation plays a major role in coronavirus disease (COVID-19). Factors
that convey information about the status of inflammation could predict disease severity and …

Background: Severe acute respiratory syndrome Coronavirus 2 (SARS-COV 2) infection
elicits an inflammatory response which is responsible for severe clinical manifestations …

Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Several reports highlighted the central role of inflammation in the pathogenesis of corona
virus disease-19 (COVID-19) disease. Also, the hyper-inflammatory response that is …

Background Being highly infectious disease, COVID-19 exhausts most of efficient healthcare
systems worldwide. Simple and rapid risk stratification methods are mandatory to recognize …

Background: The clinical presentations in patients with SARS-CoV-2 (COVID-19) infections
range from asymptomatic upper respiratory infections to acute respiratory failure with …